Literature DB >> 7643353

Alagille syndrome: family studies.

F V Elmslie1, A J Vivian, H Gardiner, C Hall, A P Mowat, R M Winter.   

Abstract

Alagille syndrome (AGS) is one of the major forms of chronic liver disease in childhood with severe morbidity and a mortality of 10 to 20%. It is characterised by cholestasis of variable severity with paucity of interlobular bile ducts and anomalies of the cardiovascular system, skeleton, eyes, and face. Previous studies suggest a wide variation in the expression of the disease and a high incidence of new mutations. To determine more accurately the rate of new mutations and to develop criteria for detecting the disorder in parents we systematically investigated parents in 14 families with an affected child. Clinical examination was supplemented by liver function tests, echocardiography, radiographic examination of the spine and forearm, ophthalmological assessment, and chromosome analysis. Six parents had typical anomalies in two or more systems pointing to the presence of autosomal dominant inheritance. Systematic screening of parents for the features defined in this study should improve the accuracy of genetic counselling.

Entities:  

Mesh:

Year:  1995        PMID: 7643353      PMCID: PMC1050372          DOI: 10.1136/jmg.32.4.264

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  18 in total

1.  Arteriohepatic dysplasia: familial pulmonary arterial stenosis with neonatal liver disease.

Authors:  G H Watson; V Miller
Journal:  Arch Dis Child       Date:  1973-06       Impact factor: 3.791

2.  Hereditary cholestasis combined with peripheral pulmonary stenosis and other anomalies.

Authors:  N T Henriksen; F Langmark; S J Sorland; O Fausa; S Landaas; O Aagenaes
Journal:  Acta Paediatr Scand       Date:  1977-01

3.  Segregation analysis of Alagille syndrome.

Authors:  S Dhorne-Pollet; J F Deleuze; M Hadchouel; C Bonaïti-Pellié
Journal:  J Med Genet       Date:  1994-06       Impact factor: 6.318

4.  Syndrome of intrahepatic biliary dysgenesis and cardiovascular malformations.

Authors:  R D Greenwood; A Rosenthal; A C Crocker; A S Nadas
Journal:  Pediatrics       Date:  1976-08       Impact factor: 7.124

5.  Arteriohepatic dysplasia: phenotypic features and family studies.

Authors:  R F Mueller; R A Pagon; M G Pepin; J E Haas; I Kawabori; J G Stevenson; M J Stephan; J D Blumhagen; D L Christie
Journal:  Clin Genet       Date:  1984-04       Impact factor: 4.438

6.  Arteriohepatic dysplasia: a benign syndrome of intrahepatic cholestasis with multiple organ involvement.

Authors:  C A Riely; E Cotlier; P S Jensen; G Klatskin
Journal:  Ann Intern Med       Date:  1979-10       Impact factor: 25.391

7.  Arteriohepatic dysplasia (Alagille syndrome): extreme variability among affected family members.

Authors:  S A Shulman; J S Hyams; R Gunta; R M Greenstein; S B Cassidy
Journal:  Am J Med Genet       Date:  1984-10

8.  Anterior chamber cleavage syndrome. A stepladder classification.

Authors:  G O Waring; M M Rodrigues; P R Laibson
Journal:  Surv Ophthalmol       Date:  1975 Jul-Aug       Impact factor: 6.048

9.  Arteriohepatic dysplasia: radiologic features of a new syndrome.

Authors:  N S Rosenfield; M J Kelley; P S Jensen; E Cotlier; A T Rosenfield; C A Riely
Journal:  AJR Am J Roentgenol       Date:  1980-12       Impact factor: 3.959

10.  Studies of the aetiology of neonatal hepatitis and biliary atresia.

Authors:  D M Danks; P E Campbell; I Jack; J Rogers; A L Smith
Journal:  Arch Dis Child       Date:  1977-05       Impact factor: 3.791

View more
  11 in total

1.  Alagille syndrome in a Vietnamese cohort: mutation analysis and assessment of facial features.

Authors:  Henry C Lin; Phuc Le Hoang; Anne Hutchinson; Grace Chao; Jennifer Gerfen; Kathleen M Loomes; Ian Krantz; Binita M Kamath; Nancy B Spinner
Journal:  Am J Med Genet A       Date:  2012-04-09       Impact factor: 2.802

2.  Spectrum and frequency of jagged1 (JAG1) mutations in Alagille syndrome patients and their families.

Authors:  I D Krantz; R P Colliton; A Genin; E B Rand; L Li; D A Piccoli; N B Spinner
Journal:  Am J Hum Genet       Date:  1998-06       Impact factor: 11.025

Review 3.  Alagille syndrome.

Authors:  I D Krantz; D A Piccoli; N B Spinner
Journal:  J Med Genet       Date:  1997-02       Impact factor: 6.318

Review 4.  Alagille syndrome.

Authors:  Michelle Hadchouel
Journal:  Indian J Pediatr       Date:  2002-09       Impact factor: 1.967

5.  Conditional JAG1 mutation shows the developing heart is more sensitive than developing liver to JAG1 dosage.

Authors:  Fengmin Lu; Jennifer J D Morrissette; Nancy B Spinner
Journal:  Am J Hum Genet       Date:  2003-03-14       Impact factor: 11.025

6.  Consequences of JAG1 mutations.

Authors:  B M Kamath; L Bason; D A Piccoli; I D Krantz; N B Spinner
Journal:  J Med Genet       Date:  2003-12       Impact factor: 6.318

7.  Alagille syndrome and pregnancy.

Authors:  Adam Morton; Sailesh Kumar
Journal:  Obstet Med       Date:  2019-06-09

8.  THBS2 Is a Candidate Modifier of Liver Disease Severity in Alagille Syndrome.

Authors:  Ellen A Tsai; Melissa A Gilbert; Christopher M Grochowski; Lara A Underkoffler; He Meng; Xiaojie Zhang; Michael M Wang; Hailu Shitaye; Kurt D Hankenson; David Piccoli; Henry Lin; Binita M Kamath; Marcella Devoto; Nancy B Spinner; Kathleen M Loomes
Journal:  Cell Mol Gastroenterol Hepatol       Date:  2016-05-26

9.  Alagille syndrome: Genetics and Functional Models.

Authors:  Melissa A Gilbert; Nancy B Spinner
Journal:  Curr Pathobiol Rep       Date:  2017-09

10.  Hypertension and Biliary Ductopenia in a Patient with Duplication of Exon 6 of the JAG1 Gene.

Authors:  J Uberos; L Moreno; A Muñoz-Hoyos
Journal:  Clin Med Insights Pediatr       Date:  2012-07-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.